← All candidates
One insider buy in the last year — $1.05M in all.
71 filings on record.
HTFLHeartflow, Inc.
NasdaqGS · Healthcare · $4.20B
$48.33
-2.44% · Sep 15
One insider buy in the last year — $1.05M in all.
Nothing in the last fortnight.
Price · 1Y · daily● 1 buy● 16 sells◆ 1 8-K
▸ hover a marker for the filing · drag to zoom · daily bars sharpen to 30-min on close ranges · 4 moves explained
AI brief · from the filings on this pagePro
The filings, the score and the setup on this page, read for you in about ten seconds — what the insiders did, and what stands against it.
Market cap
$4.20B
Float
67.1M
77% public
Short % float
Pro
Price / profit
—
not yet profitable
Price / future profit
—
Price / sales
19.8
The buyers
▸ each insider's past open-market buys, measured ~6 months (120 trading days) later, against the S&P over the same spans · split-adjusted · pre-scheduled 10b5-1 plan trades excluded · past outcomes, not predictions
Director
Lightcap Jeffrey C
Bought $1.05M on Dec 16 — 40,000 sh @ $26.34, held direct, 100% of their stake.
1 of 1 position beat the S&P
Institutional stakes
▸ a holder crossing 5% files Schedule 13D if they intend to act on the company, 13G if they certify they will not · /A amends an earlier filing
1 filingnewest first
The record
newest first
DateTypeInsiderOf stakeShares @ priceValue
66 more transactions on Pro →Context
Wall St
$37.00 avg target
-23.4% vs today · 7 analysts · consensus Strong Buy
▸ relayed analyst opinion, which tends to run optimistic — not our forecast or advice
Earnings · EPS vs forecast
2 of 4 quarters beat
Q1 '26−$0.16 act+$0.01
Q4 '25−$0.12 act+$0.04
Q3 '25−$0.27 act−$0.03
Q2 '25−$1.10 act−$0.89
Coverage
What Does the HeartFlow CEO's Sale of Over 20,000 Company Shares Mean for Investors?Motley Fool · 07-15Heartflow vs. Omeros: Which Healthcare Innovator Stock Is a Better Buy in 2026?Motley Fool · 07-08Heartflow vs. Iovance Biotherapeutics: Which Healthcare Stock Is a Better Buy in 2026?Motley Fool · 07-04
The file stays open
71 filings on record.
The next one will be too.
▸ SEC EDGAR · FINRA · Nasdaq — public sources only · research, not advice